TCMDTACTILE SYSTEMS TECHNOLOGY INC
Surgical & Medical Instruments & Apparatus
- Revenue
- $330M
- 12% YoY
- Operating margin
- 8.9%
- 17% YoY
- EBITDA
- $36M
- 24% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- -1.9×
- −$70M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear224% of net incomeCash flow under 80% of net income
- Dilutive SBCClear3% of revenueOver 10% of revenue
- Payouts exceed cash flowClear62% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear14% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $208M | $247M | $274M | $293M | $330M | 12% |
| Operating income | −$2M | −$13M | $18M | $22M | $29M | 32% |
| Net income | −$12M | −$18M | $29M | $17M | $19M | 13% |
| Operating cash flow | $3M | $5M | $36M | $41M | $43M | 5.3% |
| Capex | $2M | $2M | $2M | $2M | $2M | 0.5% |
| Stock-based comp | $10M | $10M | $8M | $8M | $8M | 6.9% |
| Buybacks | — | — | — | $4M | $27M | 657% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $431K · 2
- Net
- −$431K
Pay vs performance
No pay-versus-performance disclosure yet.